Has Kort Knudson received payments from drug or device companies?

Yes. Drug and device makers reported $7,787 in general payments to Kort Knudson across 388 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kort Knudson did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kort Knudson come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kort Knudson

Endocrinology, Diabetes & Metabolism · West Palm Beach, FLNPI 1982627907

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $6,684 of the $7,787 with a category attached, or 85.8%. It is spread thinly across 42 manufacturers, the largest accounting for just 15.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $4,248 and has fallen 85.5% since, to $616 in 2022.

$7,787in general payments, 2019–2025

Across 388 payments — averaging $20.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novo Nordisk$1K
Tosoh Bioscience, Inc.$1K
AstraZeneca$683
Lilly USA, LLC$639
Amgen$485
Sanofi-aventis U.S. LLC$303
plus $3K from 36 others

What the payments were for

Food & beverage$6,68486%
Education$250%
Gifts$1,07814%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novo Nordisk	90	$1,176
Tosoh Bioscience, Inc.	2	$1,078
AstraZeneca	35	$683
Lilly USA, LLC	44	$639
Amgen(2 entities)	22	$485
Sanofi-aventis U.S. LLC	19	$303
Merck	22	$287
Mannkind Corporation	11	$243
Boehringer Ingelheim	12	$238
Abbott	13	$223
Xeris Pharmaceuticals, Inc.	12	$210
Amarin Pharma, Inc.	11	$201
Johnson & Johnson	11	$189
Radius Health, Inc.	8	$148
Valeritas, Inc.	7	$148
W. L. Gore & Associates, Inc.	1	$147
Tandem Diabetes Care, Inc.	2	$138
Antares Pharma, Inc.	8	$138
AbbVie	8	$132
Ipsen Biopharmaceuticals, Inc	1	$125
Medtronic(2 entities)	8	$112
Insulet Corporation	5	$92
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	5	$90
Lifescan, Inc.	4	$80
Amneal Pharmaceuticals LLC	4	$55
Bayer	2	$45
Vivus LLC	3	$45
Recordati_rare_diseases_inc.	2	$41
Shire North American Group Inc	2	$35
Quidel Corporation	1	$32
Currax Pharmaceuticals LLC	2	$31
Zealand Pharma US, Inc.	1	$23
Takeda Pharmaceuticals U.S.A., Inc.	1	$22
EUSA Pharma (US) LLC	1	$21
Corcept Therapeutics	1	$21
Vistapharm, Inc.	1	$20
Ultragenyx Pharmaceutical Inc.	1	$20
Nalpropion Pharmaceuticals LLC	1	$16
BD	1	$15
Kowa Pharmaceuticals America, Inc.	1	$14
IBSA Pharma Inc.	1	$14
Cequr Corporation	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

25-OH Vitamin D ST AIA-Pack$2,156
TU, AIA-PACK Calibrator Set$539
TU, ST, AIA-PACK$539
SEAMGUARD Bioabsorbable Staple Line Reinforcement$147
SOMATULINE DEPOT$125
EVENITY$122
t-slim insulin pump$119
AFREZZA$107

How this compares

$7,787 in reported general payments places this provider in the 65th percentile of 586 endocrinology, diabetes & metabolism providers in Florida.

See all endocrinology, diabetes & metabolism providers in Florida →

Other endocrinology, diabetes & metabolism in West Palm Beach

Barry HorowitzWest Palm Beach$628K
William KayeWest Palm Beach$515K
Jay SkylerMiami$2.2M
Arelis MaderaPort Charlotte$1.7M
Damon TantonOrlando$1.2M
Gaston PonteMelbourne$906K
Brian LakeLargo$888K
David SuttonJacksonville$783K
Mae Sheikh AliJacksonville$751K
Richard PratleyOrlando$735K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →